MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 205 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,519,000 | +15.3% | 143,325 | +11.2% | 0.03% | +6.9% |
| Q2 2022 | $3,919,000 | +6542.4% | 128,836 | +2282.8% | 0.03% | +2800.0% |
| Q1 2020 | $59,000 | -48.7% | 5,407 | -54.0% | 0.00% | -80.0% |
| Q4 2019 | $115,000 | -17.9% | 11,763 | -20.2% | 0.01% | +66.7% |
| Q3 2019 | $140,000 | -4.8% | 14,734 | +19.0% | 0.00% | -25.0% |
| Q2 2019 | $147,000 | +1236.4% | 12,380 | +1544.1% | 0.00% | +300.0% |
| Q4 2017 | $11,000 | -26.7% | 753 | -30.4% | 0.00% | 0.0% |
| Q3 2017 | $15,000 | – | 1,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |